USANA Launches Glow Supplement with 65% Skin Uniformity Improvement
USANA Health Sciences has launched Glow, its first ingestible skincare supplement formulated with Damasty® and clinically studied antioxidants to support collagen production, hydration and even skin tone. Clinical trials of 162 women showed up to 65% improvement in skin uniformity and 40% radiance increase after three months.
1. Product Launch and Strategic Diversification
USANA has entered the ingestible skincare market with Glow, its first cellular nutrition supplement targeting skin radiance and resilience from within. This move extends the company’s portfolio beyond topical lines and leverages its FDA-registered manufacturing infrastructure to address growing consumer demand for internal skin health solutions.
2. Ingredients and Formulation Detail
Glow is anchored by Damasty®, a proprietary blend combining rose extract, melon superoxide dismutase, acerola cherry vitamin C, astaxanthin and grape seed extract. These clinically studied antioxidants and nutrients work synergistically to support collagen synthesis, reduce oxidative stress and optimize skin hydration and tone.
3. Clinical Trial Results and Market Outlook
In a 162-participant trial, Glow delivered a 26% radiance increase at two months, 40% at three months and a 65% improvement in skin uniformity by month three. Early consumer perception measures reported 100% of participants noting enhanced radiance, positioning USANA to capitalize on a burgeoning skincare supplement segment.